✦ LIBER ✦

O-247 Molecular mechanisms of sensitivity and resistance to the HER1/EGFR-tyrosine kinase inhibitor erlotinib (Tarceva™)

✍ Scribed by Perez-Soler, Roman; Dai, Qun; Ling, Yi-He; Lee, Marie; Kroog, Glenn; Zou, Yiyu; Higentz, Missak; Iwata, Kenneth K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

118 Responses of human pancreatic tumour

✍ N. Ioannou; A. Dalgleish; A.M. Seddon; D. Mackintosh; U. Guertler; F. Solca; H. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

PO-10 In vivo efficacy of HER1/EGFR tyro

✍ C. Festuccia; G.L. Gravina; P. Muzi; A. Vetuschi; R. Sferra; C. Vicentini; M. Bo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB

mTOR inhibitors and the anti-diabetic bi

✍ Alejandro Vázquez-Martín; Cristina Oliveras-Ferraros; Sonia del Barco; Begoña Ma 📂 Article 📅 2009 🏛 Springer Milan 🌐 Spanish ⚖ 470 KB

O-112 A phase I/II study of the anti-VEG

✍ Sandler, Alan B.; Mininberg, Eric; Henderson, Ted; Kim, Edward; Hong, Waun Ki; M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB